Uveitis Treatment Market: Steady Growth Expected With A 5.8% CAGR Through 2034
Uveitis Treatment Market Analysis of Uveitis Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, ...
Ophthalmology Times1d
Preclinical study of KIO-104 in a proliferative vitreoretinopathy model accepted for poster presentation at ARVO 2025
The findings of this model support KIO-104 as a promising therapeutic candidate for both the prevention and treatment of PVR.
Kiora Pharmaceuticals to Present Preclinical Data on KIO-104 for the Treatment of Proliferative Vitreoretinopathy at the ARVO 2025 Annual Meeting
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced their abstract of a preclinical study of KIO ...
ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN Label
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME)ANI plans to begin marketing ILU ...
MPR4d
Iluvien Approved for Chronic Non-Infectious Posterior Uveitis
The Food and Drug Administration (FDA) has approved Iluvien® (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious ...
Science Daily5d
Stem Cells News
Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in ... How Healthy Stem Cells Turn Into Or ...
GB News on MSN2h
From bedwetting to writer's cramp, the success rate of EVERY benefit claim EXPOSED as Labour wields axe
From wetting the bed to acne, we have crunched the numbers on the success rate of every single disability claim. It comes ...
Medscape2d
Alternative Therapies: Turmeric
In an open clinical trial, curcumin was administered in an oral dose of 375 mg three times daily for 12 weeks to 53 patients with chronic anterior uveitis. [8] Twentyone patients dropped out of ...
Taiwan News6d
Vietnam Ophthalmic Drugs Market to Reach $824.18 Million by 2033, Growing at 9.45% CAGR
The Vietnam ophthalmic drugs market was valued at USD 478.32 million in 2024 and is expected to reach USD 824.18 million by 2033, registering a CAGR of 9.45% during the forecast period. The market is ...